Draznin B. Hirsch IB. Time to Follow the Evidence: Glycemic control and cardiovascular benefits of new diabetes medications. Am J Med 2021 (in press).
Draznin B. Hirsch IB. Time to Follow the Evidence: Glycemic control and cardiovascular benefits of new diabetes medications. Am J Med 2021; 134:420-422.
Iancu I, Pozniak E, Draznin B. Virtual patient simulation platforms challenging traditional CME: Identification of gaps in knowledge in management of Type 2 diabetes and hyperlipidemia. Journal of European CME, 10:1. Published on line Nov 22, 2021
Diabetes in Practice: Case studies with commentaries.
Hirsch IB, Draznin B. Transition of Patients to and from Insulin Degludec: A Clinical Challenge. J Clin Endocrinol Metab. 2019 Dec 16. [Epub ahead of print] PubMed PMID: 31840748
LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, Hirsch IB, McDonnell ME, Molitch ME, Murad MH, Sinclair AJ. Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019 May 1;104(5):1520-1574. PubMed PMID: 30903688
Klonoff DC, Draznin B, Drincic A, Dungan K, Gianchandani R, Inzucchi SE, Nichols JH, Rice MJ, Seley JJ. PRIDE Statement on the Need for a Moratorium on the CMS Plan to Cite Hospitals for Performing Point-of-Care Capillary Blood Glucose Monitoring on Critically Ill Patients. J Clin Endocrinol Metab. 2015 Oct;100(10):3607-12. PubMed PMID: 26398626
Hellman R, Draznin B. Do we need to broaden the scope of inpatient diabetes education to include our faculty?. Endocr Pract. 2015 Apr;21(4):448-9. PubMed PMID: 25667380